Abstract
In 2006, the global market for breast biopsy devices was valued at over $300
million.
This market is comprised of vacuum-assisted biopsy capital equipment and
disposables, core needle biopsy disposable devices and needles, fine needle
aspiration devices, and markers used for breast biopsy in the US, Europe
(France, Germany, Italy, and the UK), and Japan